- Home
- SLND vs ACIU Comparison
SLND vs ACIU Comparison
Compare SLND & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLND
- ACIU
- Stock Information
- Founded
- SLND 1900
- ACIU 2003
- Country
- SLND United States
- ACIU Switzerland
- Employees
- SLND N/A
- ACIU N/A
- Industry
- SLND Military/Government/Technical
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- SLND Industrials
- ACIU Health Care
- Exchange
- SLND Nasdaq
- ACIU Nasdaq
- Market Cap
- SLND 210.6M
- ACIU 213.3M
- IPO Year
- SLND N/A
- ACIU 2016
- Fundamental
- Price
- SLND $4.69
- ACIU $3.52
- Analyst Decision
- SLND Buy
- ACIU Strong Buy
- Analyst Count
- SLND 2
- ACIU 2
- Target Price
- SLND $4.50
- ACIU $10.00
- AVG Volume (30 Days)
- SLND 115.9K
- ACIU 259.0K
- Earning Date
- SLND 11-11-2025
- ACIU 11-04-2025
- Dividend Yield
- SLND N/A
- ACIU N/A
- EPS Growth
- SLND N/A
- ACIU N/A
- EPS
- SLND N/A
- ACIU N/A
- Revenue
- SLND $895,438,000.00
- ACIU $36,362,036.00
- Revenue This Year
- SLND N/A
- ACIU N/A
- Revenue Next Year
- SLND $3.50
- ACIU $1,022.98
- P/E Ratio
- SLND N/A
- ACIU N/A
- Revenue Growth
- SLND N/A
- ACIU 86.71
- 52 Week Low
- SLND $1.85
- ACIU $1.43
- 52 Week High
- SLND $4.90
- ACIU $3.99
- Technical
- Relative Strength Index (RSI)
- SLND 59.75
- ACIU 67.07
- Support Level
- SLND $4.15
- ACIU $2.70
- Resistance Level
- SLND $4.70
- ACIU $3.99
- Average True Range (ATR)
- SLND 0.28
- ACIU 0.30
- MACD
- SLND 0.02
- ACIU 0.10
- Stochastic Oscillator
- SLND 93.10
- ACIU 72.49
About SLND Southland Holdings Inc.
Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures. The company operates in two distinct segments: Civil and Transportation. The civil segment operates throughout North America and specializes in services that include the design and construction of water pipelines, pump stations, lift stations, water and wastewater treatment plants, concrete and structural steel, outfall, and tunneling. The transportation segment operates throughout North America and specializes in services that include the design and construction of bridges, roadways, marine, dredging, ship terminals and piers, and specialty structures and facilities.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.